BIOMAT Database Logo BIOMAT Database Logo

A case of Philadelphia Positive Acute Lymphoblastic Leukaemia with three different phenotypic lineage, each one presenting the same BCR-ABL hybrid transcript. 2009

Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010677 Philadelphia Chromosome An aberrant form of human CHROMOSOME 22 characterized by translocation of the distal end of chromosome 9 from 9q34, to the long arm of chromosome 22 at 22q11. It is present in the bone marrow cells of 80 to 90 per cent of patients with chronic myelocytic leukemia (LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE). Ph1 Chromosome,Ph 1 Chromosome,1 Chromosomes, Ph,Chromosome, Ph 1,Chromosome, Ph1,Chromosome, Philadelphia,Chromosomes, Ph 1,Chromosomes, Ph1,Ph 1 Chromosomes,Ph1 Chromosomes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016044 Fusion Proteins, bcr-abl Translation products of a fusion gene derived from CHROMOSOMAL TRANSLOCATION of C-ABL GENES to the genetic locus of the breakpoint cluster region gene on chromosome 22. Several different variants of the bcr-abl fusion proteins occur depending upon the precise location of the chromosomal breakpoint. These variants can be associated with distinct subtypes of leukemias such as PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; and NEUTROPHILIC LEUKEMIA, CHRONIC. Oncogene Protein p190(bcr-abl),Oncogene Protein p210(bcr-abl),bcr-abl Fusion Protein,bcr-abl Fusion Proteins,Bcr-Abl Tyrosine Kinase,Oncogene Protein p185(bcr-abl),Oncogene Protein p230(bcr-abl),p185(bcr-abl) Fusion Proteins,p190(bcr-abl) Fusion Proteins,p210(bcr-abl) Fusion Proteins,p230(bcr-abl) Fusion Proteins,Bcr Abl Tyrosine Kinase,Fusion Protein, bcr-abl,Fusion Proteins, bcr abl,Kinase, Bcr-Abl Tyrosine,Protein, bcr-abl Fusion,Tyrosine Kinase, Bcr-Abl,bcr abl Fusion Protein,bcr abl Fusion Proteins
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma

Related Publications

Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
Novel BCR-ABL transcript containing an intronic sequence insert in a patient with Philadelphia-positive acute lymphoblastic leukaemia.
September 2000, British journal of haematology,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
The e1a3 BCR-ABL1 fusion transcript in Philadelphia chromosome-positive acute lymphoblastic leukaemia: a case report.
December 2023, Hematology (Amsterdam, Netherlands),
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
Progression from myelodysplastic syndrome to acute lymphoblastic leukaemia with Philadelphia chromosome and p190 BCR-ABL transcript.
May 1996, British journal of haematology,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
Heterogenous expression of bcr-abl fusion mRNA in a patient with Philadelphia-chromosome-positive acute lymphoblastic leukaemia.
June 1997, British journal of haematology,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement.
June 2000, Leukemia,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
[Cytogenetic and prognostic analysis in adult patients with Philadelphia chromosome-positive and bcr-abl positive acute lymphoblastic leukaemia].
May 2009, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma.
November 1990, Leukemia,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
A novel 203 kD aberrant BCR-ABL product in a girl with Philadelphia chromosome positive acute lymphoblastic leukaemia.
December 1993, British journal of haematology,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
October 1988, Leukemia,
Matteo Parma, and Federica Colnaghi, and Arianna Colombo, and Elena Elli, and Fabio Rossi, and Giuseppe Gaipa, and Vincenzo Rossi, and Ivana Casaroli, and Andrea Biondi, and Enrico Maria Pogliani
BCR-ABL rearrangements in acute lymphoblastic leukaemia.
June 1991, Lancet (London, England),
Copied contents to your clipboard!